Common Stock, Shares, Outstanding of PAVmed Inc. from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
PAVmed Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2015 to Q3 2025.
  • PAVmed Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 23,053,498, a 116% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

PAVmed Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 23,053,498 +12,393,104 +116% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 20,142,463 +10,588,082 +111% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 16,769,619 +7,911,022 +89% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 11,198,977 +2,620,472 +31% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 10,660,394 -109,041,565 -91% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 9,554,381 -98,983,613 -91% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 8,858,597 -91,737,809 -91% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 8,578,505 +2,277,802 +36% 31 Dec 2023 10-K 24 Mar 2025 2024 FY
Q3 2023 119,701,959 +27,473,097 +30% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 108,537,994 +21,514,783 +25% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 100,596,406 +13,684,760 +16% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 6,300,703 -80,067,142 -93% 31 Dec 2022 10-K 25 Mar 2024 2023 FY
Q3 2022 92,228,862 +7,828,040 +9.3% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 87,023,211 +4,446,395 +5.4% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 86,911,646 +5,486,902 +6.7% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 86,367,845 +22,547,910 +35% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 84,400,822 +34,744,907 +70% 30 Sep 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 82,576,816 +34,657,816 +72% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 81,424,744 +37,290,999 +84% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 63,819,935 +23,341,074 +58% 31 Dec 2020 10-K 06 Apr 2022 2021 FY
Q3 2020 49,655,915 +13,099,737 +36% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 47,919,000 +13,779,780 +40% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 44,133,745 +16,940,722 +62% 31 Mar 2020 10-Q 28 May 2020 2020 Q1
Q4 2019 40,478,861 +13,335,882 +49% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 36,556,178 +10,013,199 +38% 30 Sep 2019 10-Q 19 Nov 2019 2019 Q3
Q2 2019 34,139,220 +7,629,566 +29% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 27,193,023 +9,683,369 +55% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 27,142,979 +12,591,745 +87% 31 Dec 2018 10-K 14 Apr 2020 2019 FY
Q3 2018 26,542,979 +13,199,918 +99% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 26,509,654 +13,178,443 +99% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 17,509,654 +4,178,443 +31% 31 Mar 2018 10-Q 21 May 2018 2018 Q1
Q4 2017 14,551,234 +1,220,423 +9.2% 31 Dec 2017 10-K 14 Apr 2020 2019 FY
Q3 2017 13,343,061 +33,061 +0.25% 30 Sep 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 13,331,211 +21,211 +0.16% 30 Jun 2017 10-Q 11 Aug 2017 2017 Q2
Q1 2017 13,331,211 +1,081,211 +8.8% 31 Mar 2017 10-Q 22 May 2017 2017 Q1
Q4 2016 13,330,811 +1,080,811 +8.8% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 13,310,000 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 13,310,000 30 Jun 2016 10-Q 12 Aug 2016 2016 Q2
Q1 2016 12,250,000 31 Mar 2016 10-Q/A 20 May 2016 2016 Q1
Q4 2015 12,250,000 31 Dec 2015 10-K 16 Feb 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.